140 related articles for article (PubMed ID: 22322729)
21. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
22. In search of malignant transformation: a pilot study.
Nayyar AS; Khan M
J Cancer Res Ther; 2012; 8(2):277-81. PubMed ID: 22842375
[TBL] [Abstract][Full Text] [Related]
23. Progressive rise of c fos expression from premalignant to malignant lesions of oral cavity.
Sachdev R; Mandal AK; Singh I; Agarwal AK
Med Oral Patol Oral Cir Bucal; 2008 Nov; 13(11):E683-6. PubMed ID: 18978706
[TBL] [Abstract][Full Text] [Related]
24. Estimation of serum lactate dehydrogenase level in patients with oral premalignant lesions/conditions and oral squamous cell carcinoma: a clinicopathological study.
Pereira T; Shetty S; Pereira S
J Cancer Res Ther; 2015; 11(1):78-82. PubMed ID: 25879341
[TBL] [Abstract][Full Text] [Related]
25. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
Tomasević Z; Jelić S
Arch Immunol Ther Exp (Warsz); 2000; 48(3):195-200. PubMed ID: 10912625
[TBL] [Abstract][Full Text] [Related]
26. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer.
Sawhney H; Kumar CA
Cancer Biomark; 2011-2012; 10(1):43-9. PubMed ID: 22297551
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
Lee YY; Choi CH; Sung CO; Do IG; Huh S; Song T; Kim MK; Kim HJ; Kim TJ; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):92-7. PubMed ID: 22014631
[TBL] [Abstract][Full Text] [Related]
28. Changes of circulating immune complexes in the serum and CSF of patients with multiple sclerosis.
Cojocaru M; Cojocaru MI; Steriu O; Băldescu R
Rom J Intern Med; 1992; 30(1):51-6. PubMed ID: 1496259
[TBL] [Abstract][Full Text] [Related]
29. Lymphocyte populations in premalignant lesions and cancer of the oral cavity.
Pillai MR; Balaram P; Abraham T; Nair MK
Neoplasma; 1987; 34(4):469-79. PubMed ID: 3498910
[TBL] [Abstract][Full Text] [Related]
30. Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma.
Hsieh PC; Chen YK; Tsai KB; Shieh TY; Chang YY; Chang JG; Wu HL; Lin SF
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):257-67. PubMed ID: 19926498
[TBL] [Abstract][Full Text] [Related]
31. Circulating immune complexes as an immunological marker in premalignant and malignant lesions of the oral cavity.
Remani P; Ankathil R; Vijayan KK; Haseena Beevi VM; Rajendran R; Vijayakumar T
Cancer Lett; 1988 Jun; 40(2):185-91. PubMed ID: 3383176
[TBL] [Abstract][Full Text] [Related]
32. Quantification of polyethylene glycol precipitable circulating immune complex from carcinoma of cervix patients.
Das S
Arch Geschwulstforsch; 1987; 57(4):283-6. PubMed ID: 3675140
[TBL] [Abstract][Full Text] [Related]
33. Lipid peroxidation, total antioxidant status, and total thiol levels predict overall survival in patients with oral squamous cell carcinoma.
Patel BP; Rawal UM; Dave TK; Rawal RM; Shukla SN; Shah PM; Patel PS
Integr Cancer Ther; 2007 Dec; 6(4):365-72. PubMed ID: 18048884
[TBL] [Abstract][Full Text] [Related]
34. [Precancerous lesions of the buccal mucosa].
Ben Slama L
Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145
[TBL] [Abstract][Full Text] [Related]
35. Expression of lectin binding in oral submucous fibrosis.
Beena VT; Anil S; Remani P; Vijayakumar T
Indian J Dent Res; 1998; 9(3):85-90. PubMed ID: 10530194
[TBL] [Abstract][Full Text] [Related]
36. Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients.
Tamaki S; Sanefuzi N; Kawakami M; Aoki K; Imai Y; Yamanaka Y; Yamamoto K; Ishitani A; Hatake K; Kirita T
Hum Immunol; 2008 Feb; 69(2):88-93. PubMed ID: 18361932
[TBL] [Abstract][Full Text] [Related]
37. Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling.
Chang KP; Chang YT; Liao CT; Yen TC; Chen IH; Chang YL; Liu YL; Chang YS; Yu JS; Wu CC
Clin Chim Acta; 2011 May; 412(11-12):980-7. PubMed ID: 21315702
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment interleukin-6 serum levels are associated with patient survival for oral cavity squamous cell carcinoma.
Chang KP; Kao HK; Wu CC; Fang KH; Chang YL; Huang YC; Liu SC; Cheng MH
Otolaryngol Head Neck Surg; 2013 May; 148(5):786-91. PubMed ID: 23426713
[TBL] [Abstract][Full Text] [Related]
39. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients.
van der Meij EH; Mast H; van der Waal I
Oral Oncol; 2007 Sep; 43(8):742-8. PubMed ID: 17112770
[TBL] [Abstract][Full Text] [Related]
40. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma.
Rhodus NL; Ho V; Miller CS; Myers S; Ondrey F
Cancer Detect Prev; 2005; 29(1):42-5. PubMed ID: 15734216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
